GSK Stock News
$GSK · NYSE · 1 stories in 30 daysBORSA has published 1 story on GSK in the past 30 days. BORSA’s news read on GSK is bullish at 58/100, unchanged over 24 hours, based on 1 company event over the past 30 days. GSK’s next earnings report is scheduled for Wednesday, Oct 28 before the open.
The wire on $GSK
newest first · updated · direct subject stories onlyWolfe Research started coverage of GSK plc (GSK) with an Outperform rating and a $70 price target. The initiation is a positive signal from a new covering analyst.
bullish 65 · impact 30The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.
GSK stock: common questions
What is the latest GSK stock news?
The highest-impact GSK story BORSA published in the past 30 days:
· Wolfe Research initiates GSK coverage with Outperform, $70 targetIs the news on GSK bullish or bearish?
BORSA’s news read on GSK is bullish at 58/100, unchanged over 24 hours, based on 1 company event over the past 30 days. It measures the news only: it is separate from price action and is not investment advice.